Vitbee 1000
Active substance
ATC code
Species
Cattle and horses, calves and foals.
Indications
As an aid in raising Vitamin B12 levels in cattle and horses, calves and foals.
For use in the treatment of Vitamin B12 deficiency, and for poor growth rates and general unthriftiness in young animals when associated with the above deficiency.
Dose to be administered and administration route
Cattle and horses 1-3 ml
Calves and foals 0.5-1 ml
By intra-muscular or subcutaneous injection.
Repeat in 7 days if required.
Following treatment, the vitamin B12 status of herbivores should be maintained by dietary supplementation with cobalt.
Adverse reactions
None known.
Dispensing
POM-VPS - Prescription Only Medicine – Veterinarian, Pharmacist, SQPSUMMARY OF PRODUCT CHARACTERISTICS
1. NAME OF THE VETERINARY MEDICINAL PRODUCT
Vitbee 1000, 0.100 % w/v Solution for Injection
2. QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substance
Qualitative composition Cyanocobalamin Excipients Phenol |
Quantitative composition 0.100 % w/v 0.500 % w/v |
For a full list of excipients, see section 6.1.
3. PHARMACEUTICAL FORM
Solution for injection.
A clear, red, sterile solution for injection.
4. CLINICAL PARTICULARS
4.1 Target species
Cattle and horses, calves and foals.
4.2 Indications for use, specifying the target species
As an aid in raising Vitamin B12 levels in cattle and horses, calves and foals.
For use in the treatment of Vitamin B12 deficiency, and for poor growth rates and general unthriftiness in young animals when associated with the above deficiency.
4.3 Contraindications
Do not give by the intravenous route.
4.4 Special warnings for each target species
None known.
4.5 Special precautions for use
i. Special precautions for use in animals
Observe normal aseptic precautions.
ii. Special precautions for the person administering the veterinary medicinal product to animals
Care should be taken to avoid accidental self-injection or ingestion. In the case of accidental self-injection or ingestion, seek medical advice as a precautionary measure.
Following skin/eye contamination, wash/irrigate area thoroughly with cold water. Seek medical attention if irritation persists. Wash hands after use.
4.6 Adverse reactions (frequency and seriousness)
None known.
4.7 Use during pregnancy, lactation or lay
Not contraindicated in pregnant or lactating animals.
4.8 Interaction with other medicinal products and other forms of interaction
None known.
4.9 Amount(s) to be administered and administration route
Cattle and horses 1-3 ml
Calves and foals 0.5-1 ml
By intra-muscular or subcutaneous injection.
Repeat in 7 days if required.
Following treatment, the vitamin B12 status of herbivores should be maintained by dietary supplementation with cobalt.
4.10 Overdose (symptoms, emergency procedures, antidotes), if necessary
Overdosage is unlikely.
4.11 Withdrawal period(s)
Meat: zero days. Milk: zero hours.
5. PHARMACOLOGICAL PROPERTIES
Pharmacotherapeutic group:
Cyanocobalamin
ATC Vet Code:
QB03BA01
5.1 Pharmacodynamic properties
B vitamins are not stored in the body to any great extent.
5.2 Pharmacokinetic properties
The metabolism of cyanocobalamin is complex and is associated closely with that of folic acid and of ascorbic acid. It is important for maintenance of normal haemopoiesis, protection of the liver, maintenance of muscle tissue, healthy skin, brain and pancreatic metabolism.
6. PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Phenol
Sodium acid phosphate dihydrate
Sodium chloride
Water for injections
6.2 Incompatibilities
None known.
6.3 Shelf life
Shelf life of the veterinary medicinal product as packaged for sale: 2 years.
Shelf life after first opening the immediate packaging: 28 days.
6.4 Special precautions for storage
Do not store above 25°C. Protect from light.
6.5 Nature and composition of immediate packaging
50 ml type I amber glass vial, fitted with a red type I bung and
aluminium overseal.
Secondary packaging: cardboard carton.
6.6 Special precautions for the disposal of unused veterinary medicinal product or waste materials derived from the use of such products, if appropriate
Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with local requirements.
7. MARKETING AUTHORISATION HOLDER
Alfasan Nederland B.V.
Kuipersweg 9
3449 JA Woerden The Netherlands
8. MARKETING AUTHORISATION NUMBER
Vm 36408/4012
9. DATE OF FIRST AUTHORISATION
26 February 1993
10. DATE OF REVISION OF THE TEXT
August 2021
Approved: 18/08/21

Art. Nr. | |
---|---|
EAN | 5055031419296 |